awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35562290-09A5C8EB-B25E-44BB-ABE6-A0474361503F
Q35562290-09A5C8EB-B25E-44BB-ABE6-A0474361503F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35562290-09A5C8EB-B25E-44BB-ABE6-A0474361503F
Introducing vedolizumab to clinical practice: who, when, and how?
P2860
Q35562290-09A5C8EB-B25E-44BB-ABE6-A0474361503F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35562290-09A5C8EB-B25E-44BB-ABE6-A0474361503F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d1bdc1cd47dc9b272139d540b529db0907f15e35
P2860
Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype.